

Seven small-cap stocks have surged as much as 123% in early July on buyouts, FDA developments, refinancing deals and short squeezes.
You can purchase shares of Verastem (NASDAQ:VSTM) through any online brokerage.
Other companies in Verastem’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Verastem has a consensus price target of $15.36.
The stock price for Verastem (NASDAQ: VSTM) is $10 last updated October 23, 2026 at 5:47 PM EDT.
There are no upcoming dividends for Verastem.
Verastem does not have any upcoming earnings scheduled.
There is no upcoming split for Verastem.
Verastem is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote...